GTHX

G1 Therapeutics, Inc. Common Stock
GTHX

Overview Fund Activity
Delisted

GTHX was delisted on the 17th of September, 2024.

Back to rankings

96 hedge funds and large institutions have $51.5M invested in G1 Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 37 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
96
Holders Change
-19
Holders Change %
-16.52%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
31
Reduced
37
Closed
29
Calls
$431K
Puts
$121K
Net Calls
+$310K
Net Calls Change
+$101K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$2.59M
2
Bank of America
2
Bank of America
North Carolina
$1.62M
3
AQR Capital Management
3
AQR Capital Management
Connecticut
$743K
4
RJA
4
Raymond James & Associates
Florida
$2M
5
XT
5
XTX Topco
Cayman Islands
$789K

Top Sellers

1
MB
1
MPM BioImpact
Massachusetts
$0
2
Millennium Management
2
Millennium Management
New York
$2.35M
3
RPAM
3
Rhenman & Partners Asset Management
Sweden
$0
4
WP
4
Woodline Partners
California
$806K
5
CA
5
CHI Advisors
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Fisher Asset Management
1
Fisher Asset Management
Washington
$7.3M -$229K -85,542 -3%
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$5.76M +$305K +113,904 +6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$5.34M +$174K +64,930 +3%
BlackRock
4
BlackRock
New York
$3.72M -$283K -105,611 -7%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$2.59M +$1.84M +686,025 +246%
Millennium Management
6
Millennium Management
New York
$2.35M -$2.13M -796,725 -48%
Marshall Wace
7
Marshall Wace
United Kingdom
$2.05M -$621K -231,612 -23%
RJA
8
Raymond James & Associates
Florida
$2M +$666K +248,508 +50%
Bank of America
9
Bank of America
North Carolina
$1.62M +$930K +347,052 +135%
Renaissance Technologies
10
Renaissance Technologies
New York
$1.19M -$547K -204,125 -32%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$1.17M +$225K +83,855 +24%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$1.15M -$40.4K -15,068 -3%
TCM
13
Tekla Capital Management
Massachusetts
$1.14M – – –
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$861K -$151K -56,519 -15%
WP
15
Woodline Partners
California
$806K -$1.95M -728,093 -71%
XT
16
XTX Topco
Cayman Islands
$789K +$515K +192,010 +188%
Jacobs Levy Equity Management
17
Jacobs Levy Equity Management
New Jersey
$759K +$510K +190,189 +204%
AQR Capital Management
18
AQR Capital Management
Connecticut
$743K +$743K +277,106 New
Two Sigma Advisers
19
Two Sigma Advisers
New York
$735K -$122K -45,600 -14%
Morgan Stanley
20
Morgan Stanley
New York
$705K -$288K -107,610 -29%
NIM
21
Needham Investment Management
New York
$627K +$134K +50,000 +27%
Qube Research & Technologies (QRT)
22
Qube Research & Technologies (QRT)
United Kingdom
$574K -$498K -185,797 -46%
Charles Schwab
23
Charles Schwab
California
$548K +$56.9K +21,246 +12%
State Street
24
State Street
Massachusetts
$531K +$49.4K +18,430 +10%
CSS
25
Cubist Systematic Strategies
Connecticut
$413K +$217K +80,935 +110%
1
2 3 4 5